The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eckmann, L.
Right arrow Articles by Gillin, F. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eckmann, L.
Right arrow Articles by Gillin, F. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
*NITRIC OXIDE
Medline Plus Health Information
*Giardia Infections
The Journal of Immunology, 2000, 164: 1478-1487.
Copyright © 2000 by The American Association of Immunologists

Nitric Oxide Production by Human Intestinal Epithelial Cells and Competition for Arginine as Potential Determinants of Host Defense Against the Lumen-Dwelling Pathogen Giardia lamblia1

Lars Eckmann2,*, Fabrice Laurent3,*, T. Dianne Langford{dagger}, Michael L. Hetsko{dagger}, Jennifer R. Smith*, Martin F. Kagnoff* and Frances D. Gillin{dagger},{ddagger}

* Department of Medicine, University of California at San Diego, La Jolla, CA 92093; and {dagger} Department of Pathology and {ddagger} Center for Molecular Genetics, University of California at San Diego, San Diego, CA 92103


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Giardia lamblia infection of the human small intestine is a common protozoan cause of diarrheal disease worldwide. Although infection is luminal and generally self-limiting, and secretory Abs are thought to be important in host defense, other defense mechanisms probably affect the duration of infection and the severity of symptoms. Because intestinal epithelial cells produce NO, and its stable end products, nitrite and nitrate, are detectable mainly on the apical side, we tested the hypothesis that NO production may constitute a host defense against G. lamblia. Several NO donors, but not their control compounds, inhibited giardial growth without affecting viability, suggesting that NO is cytostatic rather than cytotoxic for G. lamblia. NO donors also inhibited giardial differentiation induced by modeling crucial environmental factors, i.e., encystation induced by bile and alkaline pH, and excystation in response to gastric pH followed by alkaline pH and protease. Despite the potent antigiardial activity of NO, G. lamblia is not simply a passive target for host-produced NO, but has strategies to evade this potential host defense. Thus, in models of human intestinal epithelium, G. lamblia inhibited epithelial NO production by consuming arginine, the crucial substrate used by epithelial NO synthase to form NO. These studies define NO and arginine as central components in a novel cross-talk between a luminal pathogen and host intestinal epithelium.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
G;-2qiardia lamblia is among the most common causes of protozoan infections of the human intestine and is a leading cause of diarrheal disease worldwide (1). In the United States, prevalence rates of Giardia infection range from <1% to up to 7%, depending on the population sampled, and up to 25% of total cases of giardiasis are from waterborne outbreaks (1). Symptomatic infection is characterized by diarrhea, epigastric pain, nausea, and vomiting, although their severity and duration vary considerably and are only observed in 20–80% of all stool-positive Giardia infections (1, 2). Giardiasis is self-limiting in the vast majority of cases (2), indicating effective host defense mechanisms, although chronic cases in the absence of apparent immunodeficiencies are common (1). Because G. lamblia produces no known toxin or virulence factor (3), it is not clear what key interactions between pathogen and host determine the great variability in clinical symptoms or duration of infection.

The parasite exists in two forms, the infectious cyst, which is resistant to many environmental factors, and the disease-causing trophozoite, which colonizes the intestinal lumen but does not invade the mucosa (4, 5). Excystation of ingested cysts occurs in response to luminal host signals, specifically the low pH encountered during passage through the stomach, followed by the elevated pH and proteases of the duodenum (6). Differentiation of trophozoites into cysts is induced by an elevated pH and bile, characteristic of the small intestine (6).

G. lamblia mostly colonizes the duodenum and jejunum, although a significant proportion of patients also have ileal and, occasionally, colonic colonization (7). Despite the often dramatic symptoms of infection, in >95% of patients with nonspecific gastrointestinal complaints and Giardia-positive duodenal biopsies, the duodenal mucosa was considered normal, i.e., without inflammation or grossly altered epithelium, although some degree of villous shortening often can be seen (7). Only a small fraction (3–4%) of patients with Giardia-positive duodenal biopsies have some degree of duodenitis with infiltration of neutrophils and lymphocytes (7). Despite the lack of an inflammatory response, Giardia infection induces a host immune response, as primary infection of mice with Giardia muris confers protection against secondary challenge (8, 9). In G. muris-infected mice, CD4 T cells and B cells are important for clearing the infection (8, 9, 10), while CD8 T cells and NK cells play no role in parasite clearance (8, 11). Similar conclusions appear to apply also to G. lamblia pathogenesis (12), although the host response to G. lamblia has been characterized less extensively. Among potential host effector mechanisms, antigiardial Abs, particularly of the IgA isotype, are thought to play an important role in parasite clearance (13), although Xid mice do not clear a primary Giardia infection despite high levels of antigiardial IgA (10), and IgA-deficient patients have only a slight increase in the incidence of G. lamblia infection (14). This suggests that other host defense mechanisms also play a role in Giardia clearance. For example, defensins, small anti-microbial peptides produced by intestinal epithelial cells, and lactoferrin can kill G. lamblia in vitro (15, 16), although their roles in vivo are not known.

NO is antimicrobial for a wide range of bacterial and parasitic pathogens (17, 18, 19) and has multiple other functions, including a role in neurotransmission and regulation of mucosal barrier integrity and vascular tone in the gut (20). NO is produced enzymatically from arginine through the action of NO synthase (NOS)4, which exists in three isoforms, neuronal NOS (NOS1), inducible NOS (iNOS; NOS2), and endothelial NOS (NOS3). In many cell types, the expression of iNOS is inducible by cytokines and microbial products, and iNOS is the major NOS isoform expressed by intestinal epithelial cells (21, 22). Expression of iNOS in these cells can either be constitutive, as in mouse ileum (23) and isolated normal human duodenocytes (24), or inducible in vivo during colonic inflammation (25) or in vitro by cytokines (21) or in response to infection with invasive bacteria (22, 26). In polarized intestinal epithelial cells, the stable NO end products, nitrite and nitrate, are preferentially detected at the apical side, suggesting that relevant targets for epithelial cell-derived NO and its metabolites may be located on the luminal side of the cells (22).

Because trophozoites colonize in close apposition to epithelial cells in the small intestine (5), epithelial NO production may be a potential host defense against G. lamblia. Therefore, in the present studies, we evaluated the ability of NO to affect giardial viability, growth, and differentiation. We show that NO inhibits growth, encystation, and excystation of G. lamblia, but has no effect on giardial viability. Furthermore, G. lamblia infection of human intestinal epithelial cell cultures inhibits epithelial NO production, suggesting that the parasite has evolved strategies to evade this potential host defense mechanism.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
G. lamblia

G. lamblia trophozoites (strain WB, clone C6, ATCC 30957) were cultured at 37°C in trophozoite growth medium (Diamond TYI-S-33 medium containing 10% adult bovine serum, pH 7.1, supplemented with 0.5 mg/ml bovine bile, but without added iron, vitamins, or antibiotics).

Trophozoite growth assays

Trophozoites were chilled, counted, and diluted to 104/ml in trophozoite growth medium. Freshly prepared NO donors or control compounds (e.g., GSNO, GSH, GSSG, spermine NONOate, spermine, sodium nitrite, and sodium nitrate; all obtained from Sigma, St. Louis, MO) were added at the specified concentrations, and cultures were incubated at 37°C. Cultures were harvested by chilling, and live and dead trophozoites were enumerated microscopically in the presence of trypan blue.

Encystation

In vitro encystation was conducted under conditions described previously (27). Trophozoite cultures grown to late log phase were chilled, and trophozoites (3 x 103/ml) were added to freshly prepared preencystation medium (TYI-S-33 medium containing 10% adult bovine serum, pH 7.1, with 500 µg/ml piperacillin and 125 µg/ml amikacin, but without bile). After 72 h in culture, attached trophozoites were refed with encystation medium (TYI-S-33 medium containing 10% adult bovine serum, adjusted to pH 7.8 with 1 M NaOH, supplemented with 5 mM lactic acid, 0.25 mg/ml porcine bile, and antibiotics) and cultured for an additional 18 h, after which the number of encystation-specific secretory vesicles (ESVs) was determined by Nomarski differential interference-contrast microscopy. To obtain in vitro derived cysts for excystation experiments, cultures were kept in encystation medium for a total of 66 h. Subsequently, medium containing the nonattached cells, including the cysts, was removed and centrifuged at 2200 x g for 5 min at room temperature. Trophozoites and incomplete cysts were lysed by incubation in double-distilled water for 20 min at room temperature. Cysts were washed several times with water at 4°C and stored in water at 4°C overnight before excystation experiments to lyse Giardia with incomplete cyst walls.

Excystation

In vitro excystation was conducted by a two-step method (27, 28). In vitro derived cysts were first treated with water for 60 min at 4°C (pre-excystation stage) and then suspended in an acidic excystation stage I solution (pH 4.0) that models conditions in the human stomach, containing reduced glutathione and L-cysteine in HBSS, and incubated for 20 min at 37°C. After centrifugation, the cyst pellet was resuspended in slightly alkaline excystation stage II solution (pH 8.0) that models conditions in the small intestine, containing 1 mg/ml trypsin (type 2, from porcine pancreas) in Tyrode’s salt solution, and incubated for 60 min at 37°C. Cells were collected by centrifugation and resuspended in prewarmed TYI-S-33 growth medium with bovine bile. After 30-min incubation in a water bath at 37°C, motile excysted trophozoites were counted in a hemocytometer.

Immunoblot analysis of giardial cyst wall protein 2 (CWP2) expression

For the analysis of giardial CWP2 expression, cells were harvested after 18 h of encystation and washed three times in cold PBS, with protease inhibitors in the final wash (1 mM PMSF and 1 µM trans-epoxysuccinyl-L-leucylamido(4-guanidino)-butane). Cell pellets were resuspended in cold 6% TCA, and the suspension was incubated on ice for 10 min. Lysates were centrifuged for 3 min at 13,000 rpm in a microfuge at 4°C, and pellets were snap-frozen in liquid nitrogen and stored at -80°C. After thawing, pellets were neutralized with NaOH, resuspended in SDS-PAGE sample buffer, and boiled for 6 min. Protein concentrations were determined by the Bradford method, and 6 µg protein/lane was electrophoretically size-fractionated on a 10% denaturing, reducing polyacrylamide gel. Proteins were transferred to nitrocellulose, and blots were stained with a mAb (8C5) against CWP2 (29) as described previously (30). As a control, blots were reacted with a mAb against the giardial lectin, taglin (31).

Human intestinal epithelial cell lines

HT-29 and HCT-8 human intestinal epithelial cells were obtained from American Type Culture Collection (Manassas, VA). Caco-2 human colon epithelial cells were a gift from S. Tzipori (Tufts University, North Grafton, MA). Cell lines were grown in DMEM supplemented with 10% FCS and 2 mM L-glutamine. In experiments to determine arginine dependence of epithelial NO production, cells were cultured in arginine-free DMEM supplemented with 10% dialyzed FCS (dialysis was performed for 24 h at 4°C using a dialysis membrane with a 1000 m.w. cut-off). To obtain polarized Caco-2 monolayers, 106 cells were seeded onto collagen-coated microporous filter inserts (0.4 µm pore size, 4.7 cm2 growth area; Transwells, Costar, Cambridge, MA) and cultured for 7–10 days. Development of tight junctions was confirmed by determining transepithelial resistance with a Millicell ERS electrical resistance system (Millipore, Bedford, MA).

G. lamblia infection of intestinal epithelial cell cultures

Epithelial cells were seeded into six-well tissue culture plates and grown for 1–3 days post-confluence, at which time the cultures contained 2–5 x 106 cells/well. G. lamblia trophozoites were washed twice with cold PBS and resuspended in DMEM with 10% FCS and 2 mM glutamine. Trophozoites were added to each well in a 1-ml volume, and cultures were incubated at 37°C for 18 h or the indicated times for time-course analyses. Supernatants were collected, centrifuged to remove debris, and stored at 4°C until analysis for assaying nitrite/nitrate and IL-8 and at -80°C for assaying amino acid levels. To stimulate epithelial NO and IL-8 production, a combination of 20 ng/ml human IL-1{alpha}, 20 ng/ml human TNF-{alpha}, and 50 ng/ml human IFN-{gamma} was added to the cultures at the time of infection. Viable epithelial cells at the end of the culture period were counted in the presence of trypan blue after detachment with trypsin/EDTA.

Determination of nitrite/nitrate and IL-8 in culture supernatants

To determine levels of the stable NO end products, nitrite and nitrate, nitrate was first reduced to nitrite by incubating the samples for 60 min at room temperature with 0.05 U/ml nitrate reductase (from maize, Oxford Biomedical, Oxford, MI) and 0.1 mM ß-NADH in a buffer of 25 mM MOPS (pH 7.0) and 0.5 mM EDTA. Nitrite levels were then determined using the Griess reaction. Briefly, 100 µl of supernatant or standard was mixed with 50 µl of 80 mM sulfanilamide in 2 N HCl and 50 µl of 4 mM N-1(-naphthyl)ethylenediamine dihydrochloride in water, and absorbance was determined at 550 nm. The assay was sensitive to 2 µM nitrite and nitrate. IL-8 levels were determined by ELISA as described previously (32). The assay was sensitive to 20 pg/ml IL-8.

Analysis of epithelial iNOS expression by RT-PCR and immunoblots

Total RNA was extracted using an acid guanidinium-phenol-chloroform method (Trizol, Life Technologies/BRL, Gaithersburg, MD). RT-PCR amplification was performed using previously described protocols (33). Primers for human iNOS amplification were 5'-GGT GCT GTA TTT CCT TAC GAG GCG AAG AAG G-3' (sense) and 5'-GGT GCT ACT TGT TAG GAG GTC AAG TAA AGG GC-3' (antisense). Primers for amplification of human ß-actin mRNA were previously described (33). Annealing and extension were conducted at 60°C for iNOS and 72°C for ß-actin. Amplification for 32 cycles yielded a 258-bp fragment for iNOS and a 661-bp fragment for ß-actin. Protein levels of iNOS and actin were determined by immunoblot analysis as described previously (22). Briefly, cell lysates (15 µg total protein/lane) were size-fractionated on a denaturing, nonreducing 8% polyacrylamide minigel and electrophoretically transferred to a nitrocellulose membrane (0.1 µm pore size). Specific proteins were detected using optimal concentrations of rabbit anti-human iNOS (COOH terminus; Santa Cruz Biotechnology, Santa Cruz, CA) or rabbit anti-actin (Sigma) as primary Abs, and peroxidase-conjugated donkey anti-rabbit Ig (Amersham, Arlington Heights, IL) as secondary Ab. Specifically bound peroxidase was detected by enhanced chemiluminescence (ECL system, Amersham) and exposure to x-ray film (XAR-5, Eastman Kodak, Rochester, NY) for 3 min.

HPLC analysis of amino acids

Amino acid levels in culture supernatants were analyzed by precolumn derivatization and HPLC using previously described methods (34). Supernatants were lyophilized and derivitized using a mixture of methanol, triethylamine, water, and phenylisothiocyanate. Samples were relyophilized, dissolved in a sodium phosphate/acetonitrile buffer, and analyzed by HPLC. Amino acid levels in the eluate were determined by absorbance at 254 nm and comparison with known amounts of exogenous standards, using internal standardization (methionine sulfone). The method has an independent amino acid detection limit of 50 nM.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
NO inhibits growth of G. lamblia trophozoites but has no effect on viability

We first determined whether NO affects viability or growth of G. lamblia trophozoites in vitro. Trophozoites were cultured in medium that supports optimal viability and growth (35) and exposed to compounds (NO donors) that spontaneously release NO in aqueous solution. Exposure of trophozoites to up to 5 mM of the NO donor GSNO for a relatively short time period (90 min) had no effect on their viability (data not shown), suggesting that NO is not cytotoxic for G. lamblia trophozoites under these conditions. We therefore tested whether NO donors had long term effects on trophozoites by assaying growth over several cell divisions. Under control conditions, the number of trophozoites increased approximately exponentially over a 42-h period, with a doubling time of about 8 h (Fig. 1GoA). Addition of GSNO inhibited trophozoite growth, but did not increase the number of dead trophozoites (Fig. 1GoB). The IC50 for growth inhibition by GSNO was ~0.7 mM, and growth was almost completely inhibited at 2 mM. Two control compounds, GSSG and GSH, which are structurally related to GSNO, but do not release NO, had no effect on trophozoite growth (Fig. 1GoB). Furthermore, incubation of trophozoites with up to 2 mM nitrate, which generally is the most abundant stable end product of NO, had no effect on growth (data not shown). Addition of another relatively stable NO end product, nitrite, was moderately inhibitory for trophozoite growth in a dose-dependent manner (e.g., addition of 0.1 and 1 mM nitrite inhibited growth by 25 and 40%, respectively, over a 24-h culture period). However, nitrite-induced growth inhibition was lower than that induced by identical concentrations of GSNO, and only a small fraction of NO derived from GSNO was converted to nitrite under the culture conditions (e.g., 0.3 mM nitrite was detected by the Griess reaction in Giardia culture medium containing 2 mM GSNO after incubation for 42 h without trophozoites). Moreover, GSNO is relatively stable in aqueous solution, so that only a fraction of GSNO is converted to NO over any given period of time, whereas added nitrite is present at its initial concentration throughout the entire culture period. Thus, nitrite does not appear to be primarily responsible for mediating the growth inhibitory effects of NO, although it probably contributes to the inhibition. Taken together, these data indicate that NO, or possibly one or several of its more stable metabolites, is cytostatic, but not cytotoxic, for G. lamblia trophozoites under the conditions of these studies.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 1. NO inhibits growth of G. lamblia trophozoites. A, Time course of NO-induced growth inhibition. G. lamblia trophozoites in complex growth medium were grown in the absence ({square}) or the presence of GSNO at 1 mM ({diamondsuit}) or 2 mM (•). After 18 and 42 h, the number of viable trophozoites was determined. B, Concentration dependence of NO-induced growth inhibition. Trophozoites (104/ml) in complex growth medium were grown for 42 h in the absence or the presence of the indicated concentrations of GSNO (•, {circ}), GSSG ({blacktriangledown}), or GSH ({blacktriangleup}). Subsequently, the numbers of viable (•, {blacktriangledown}, {blacktriangleup}) and dead ({circ}) trophozoites were determined by trypan blue dye exclusion. Results are the mean ± SEM (n = 4).

 
NO inhibits G. lamblia encystation

The number of G. lamblia trophozoites in the small intestine is determined in part by the balance between growth and encystation. The latter is initiated when trophozoites are exposed to a slightly alkaline pH and bile (27, 36). To further explore the role NO can play in influencing trophozoite numbers in the small intestine, we determined whether NO affects G. lamblia encystation. For these experiments, trophozoites were exposed for 18 h to conditions that efficiently induce encystation in vitro (27, 36), and the number of ESVs was determined microscopically. Formation of ESVs is a specific and relatively early event in the G. lamblia encystation pathway (37). In nonencysting trophozoite populations, <5% of cells contain ESVs (37), while after 18 h under encystation conditions >80% of cells contain one or more ESV, with some cells containing >20 ESVs (Fig. 2GoA). Addition of GSNO to encysting G. lamblia cultures completely inhibited the development of cells with >=8 ESVs/cell and decreased by >65% the average number of ESVs per positive cell, but had little effect on the percentage of cells containing at least one ESV (Fig. 2Go). The ED50 for the decrease in the number of ESVs per cell by GNSO was about 0.6 mM, and maximal effects were seen at 2 mM (Fig. 2GoC). The number of ESVs per cell also decreased after addition of a different NO donor, spermine NONOate, to encysting cultures (data not shown). The control compounds, GSSG and GSH (for GSNO) and spermine (for spermine NONOate), had little or no effect on the number of ESVs per cell (Fig. 2Go and data not shown).



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 2. NO inhibits formation of ESVs in G. lamblia. G. lamblia trophozoites were exposed to encystation stimuli in the absence (Controls) or the presence of GSNO (•), GSSG ({circ}), or GSH ({triangledown}). After 18 h, the number of ESVs was counted microscopically for at least 50 cells. A, Frequency distribution of the number of ESVs per cell in controls or after addition of 2 mM of GSNO, GSSG, or GSH in a single experiment. The average numbers of ESVs per cell in this experiment were 5.56 (controls), 1.57 (GSNO), 4.12 (GSSG), and 4.62 (GSH). B, Concentration/response curves for the percentage of cells with at least one ESV per cell. C, Concentration/response curves for the number of ESVs per cell for all ESV-positive cells (i.e., those cells that contain at least one ESV). Results are from a representative experiment. An additional experiment showed similar findings.

 
For confirmation of the ESV counts, we determined the abundance of a protein, CWP2, that is important for cyst wall formation and whose expression is specifically induced during encystation (38). Nonencysting trophozoites expressed very little CWP2, while 18-h incubation under encystation conditions strongly increased CWP2 levels (Fig. 3GoA). GSNO inhibited CWP2 expression in encysting G. lamblia cultures in a dose-dependent manner, while the control compounds GSSG and GSH had little or no effect on CWP2 levels (Fig. 3Go). Expression of a nonregulated giardial control protein, taglin, was not affected by addition of 1 mM GSNO, GSSG, or GSH to encysting cultures (data not shown). Thus, together with the ESV counts, these data show that NO inhibits G. lamblia encystation.



View larger version (49K):
[in this window]
[in a new window]
 
FIGURE 3. NO inhibits expression of giardial CWP2. Trophozoites were cultured for 18 h in complex growth medium without (A, -) or with encystation stimuli (A, +; B, all lanes) in the absence or the presence of the indicated concentrations of GSNO, GSSG, or GSH. Cell lysates were prepared and analyzed by immunoblotting for CWP2 expression. A and B show results from two separate experiments.

 
NO inhibits excystation of G. lamblia

Excystation of G. lamblia is required to establish infection in the small intestine and cause disease. This developmental step is controlled by sequential exposure to conditions that ingested cysts encounter during passage through the stomach into the duodenum, i.e., acid pH followed by alkaline pH and active proteases (28). Other host factors, such as specific Abs, can affect the excystation program and thereby the establishment of infection (27). We therefore determined whether NO, which can be produced by epithelial cells in the stomach and small intestine (23, 24, 39), affects excystation of G. lamblia. Cysts were initially kept under pre-excystation conditions (distilled water, designated pre-stage), which lyses and kills all Giardia with incomplete cyst walls, followed by incubation under acidic conditions (stage I), and then alkaline conditions in the presence of trypsin (stage II), after which the number of motile excysted trophozoites was determined microscopically. As shown in Table IGo, GSNO at 5 mM inhibited excystation of G. lamblia when present during all three excystation stages, while the control compounds GSSG and GSH had no effect on excystation. A lower dose of GSNO (2 mM) did not inhibit excystation, indicating that a 3- to 5-fold higher dose of GSNO was required for inhibition of excystation compared with inhibition of growth and encystation (Figs. 1Go and 2Go). This may be related to the thickness or relative impermeability of the cyst wall compared with the cell membrane of the vegetative stage, rather than a lower NO sensitivity of the intracellular signaling events involved in excystation compared with those in encystation or during vegetative growth. Another NO donor, spermine NONOate, also inhibited excystation, while its control compound, spermine, did not (Table IGo).


View this table:
[in this window]
[in a new window]
 
Table I. NO donors inhibit in vitro excystation of G. lamblia1

 
To define at what stages of the excystation program GSNO was effective, cysts were exposed to GSNO during only one excystation stage, while the other excystation stages were conducted under control conditions. As demonstrated in Table IGo, incubation with GSNO during excystation stage II alone was sufficient to inhibit excystation. Furthermore, GSNO had to be present during stage II to inhibit excystation, while incubation with GSNO during the pre-excystation stage and/or stage I did not inhibit excystation. Thus, the presence of an NO donor during stage II of excystation (modeling the small intestine) was necessary and sufficient for inhibiting G. lamblia excystation.

Infection of human intestinal epithelial cell cultures with G. lamblia inhibits epithelial NO production

The studies described above showed that NO donors can affect growth and differentiation of G. lamblia, suggesting that NO production may be a potential host effector mechanism. Based on this, we hypothesized that G. lamblia may have the ability to modulate this host defense, since a number of pathogens have evolved strategies to evade or take advantage of specific host responses. Intestinal epithelial cells are likely to be the most abundant producers of NO at levels relevant for the parasite, which resides in close contact to these cells in the small intestine (5). Therefore, we determined whether G. lamblia can modulate NO production by intestinal epithelial cells.

Monolayers of the human intestinal epithelial cell line, HT-29, were infected with varying numbers of G. lamblia trophozoites, and after 18 h, levels of the stable NO end products nitrite and nitrate were determined in the culture supernatants. Constitutive NO production was not detectable in these cultures before or after G. lamblia infection (Fig. 4GoA). However, G. lamblia infection inhibited NO production by >95% in HT-29 cultures stimulated with a combination of cytokines (IL-1{alpha}, TNF-{alpha}, and IFN-{gamma}) compared with that in cytokine-stimulated cultures that were not infected (Fig. 4GoA). Addition of as few as 1 trophozoite/100 epithelial cells caused half-maximal inhibition of epithelial NO production, and inhibition was maximal when >=3 trophozoites/100 epithelial cells were added to the HT-29 cultures. Furthermore, inoculation of cytokine-stimulated HT-29 cultures with G. lamblia completely inhibited NO production throughout the entire culture period (24 h), whereas in uninfected HT-29 cultures NO production began to increase within 10–12 h after cytokine stimulation and continued to increase thereafter.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 4. G. lamblia trophozoites inhibit NO production by HT-29 human intestinal epithelial cells. Confluent HT-29 monolayers in six-well plates were stimulated with a combination of IFN-{gamma}, IL-1{alpha}, and TNF-{alpha} (•) or were left unstimulated ({circ}). Both groups of cultures were infected with the indicated inocula of G. lamblia trophozoites or were left uninfected as controls. After 18 h in culture, supernatants were removed, and levels of NOx (i.e., NO2- and NO3-) were determined using the Griess reaction and nitrate reductase (A), and those of IL-8 were determined by ELISA (B). Monolayers were rinsed with cold PBS to remove trophozoites and detached using trypsin/EDTA. The numbers of viable epithelial cells were determined by trypan blue dye exclusion (C). Results are the mean ± SEM of three or more experiments. Asterisks indicate values significantly different (p < 0.05) from those in respective uninfected controls, as determined by Student’s t test.

 
The inhibitory effects of G. lamblia infection appeared to be specific for NO production, because cytokine-inducible production of another epithelial product, IL-8, was not significantly affected by G. lamblia infection for most inocula that maximally inhibited NO production, although very high inocula (10 trophozoites/epithelial cell) inhibited IL-8 production to some extent (Fig. 4GoB). These findings, together with the observation that G. lamblia infection did not affect the number of viable epithelial cells in culture (Fig. 4GoC), ruled out the possibility that G. lamblia had cytotoxic effects on the epithelial cell cultures. Furthermore, we found in additional control experiments that cultures of G. lamblia alone in the absence of epithelial cells did not consume exogenously added NO metabolites, nitrite or nitrate, or interfere with the detection of these products. G. lamblia cultures also did not produce any NO metabolites detectable using nitrate reductase and the Griess reaction. Together, these data suggest that G. lamblia interfered with epithelial NO production rather than consumed epithelial cell-derived NO or its metabolites.

To extend the findings obtained in HT-29 cells, cultures of two additional human intestinal epithelial cell lines, Caco-2 and HCT-8, were infected with G. lamblia. Cytokine-inducible NO production by these cells was also significantly inhibited by G. lamblia infection in an inoculum-dependent manner (644 ± 116 µM NOx in uninfected Caco-2 controls vs 352 ± 86 and 200 ± 67 µM after addition of 3 x 106 and 3 x 107 trophozoites, respectively; 49 ± 1 µM NOx in uninfected HCT-8 controls vs 13 ± 2 and <2 µM after addition of 105 and 106 trophozoites, respectively; mean ± SEM; n = 3–4). Caco-2 cells produced ~10-fold greater levels of NO after cytokine stimulation than HT-29 and HCT-8 cells under these conditions, and a higher trophozoite inoculum was required for inhibition of NO production by Caco-2 cells. Nonetheless, G. lamblia infection also inhibited constitutive NO production by Caco-2 cells, which, in contrast to HT-29 or HCT-8 cells, was high enough to be readily detectable (82 ± 6 µM NOx in uninfected controls vs 46 ± 8 and 31 ± 2 µM after addition of 3 x 106 and 3 x 107 trophozoites, respectively). The latter finding in conjunction with the lack of G. lamblia effects on inducible IL-8 secretion by the epithelial cells (Fig. 4GoB) strongly suggest that G. lamblia infection did not interfere with the stimulation/signaling of epithelial cells by cytokines, but, rather, affected the ability of the cells to produce NO regardless of the mode and level of stimulation. As for HT-29 cells, cell number and viability of Caco-2 cells were not affected by the infection, because total protein content (as determined by Bradford assays of cell lysates) and the ability to reduce the tetrazolium dye 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (a common measure of metabolic function) were not different in controls and G. lamblia-infected Caco-2 cultures (data not shown).

Apical G. lamblia infection of polarized intestinal epithelial cell monolayers inhibits both apical and basolateral epithelial NO release

G. lamblia is a strictly lumen-dwelling pathogen with exclusive access to the apical side of the physiologically polarized intestinal epithelium. Therefore, to further determine the physiologic relevance of the G. lamblia-induced inhibition of epithelial NO production, we used polarized monolayers of Caco-2 cells grown on collagen-coated microporous filter supports. The polarized epithelial monolayers were infected with G. lamblia on the apical side, whereas cytokine stimulation was from the basolateral side, because the cytokines, IL-1{alpha}, TNF-{alpha}, and IFN-{gamma}, used for these studies are physiologically produced by cells, such as T cells, NK cells, and macrophages, that are present in the intestinal lamina propria underlying the epithelium. As shown in Fig. 5GoA, apical G. lamblia infection inhibited total (i.e., apical and basal) epithelial NO production in response to basolateral cytokine stimulation by >80%. Constitutive epithelial NO production was also inhibited by G. lamblia infection, although the difference did not reach statistical significance. In contrast to NO production, neither constitutive nor cytokine-induced IL-8 production was significantly affected by apical G. lamblia infection of polarized Caco-2 monolayers (Fig. 5GoB and data not shown). Furthermore, consistent with a previous report (40), infection had no effect on the transepithelial resistance of the polarized monolayers (data not shown).



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 5. G. lamblia trophozoites inhibit NO production by polarized Caco-2 human intestinal epithelial cells. Cultures of confluent polarized monolayers of Caco-2 cells on collagen-coated microporous filter supports were stimulated with a combination of IFN-{gamma}, IL-1{alpha}, and TNF-{alpha} (Cytokines, +) or were left unstimulated (Cytokines, -) and were infected on the apical side with two inocula of trophozoites, 5 x 106/well (G. lamblia, +) or 2 x 107/well (G. lamblia, ++), or were left uninfected (G. lamblia, -). After 18 h in culture, supernatants were removed separately from the apical and basolateral compartments, and levels of NOx (i.e., NO2- and NO3-) were determined using the Griess reaction and nitrate reductase (A), and those of IL-8 were determined by ELISA (B). Results are the mean ± SEM of four to six experiments. Asterisks indicate values significantly different (p < 0.05) from those in the respective uninfected controls, as determined by Student’s t test.

 
G. lamblia-induced inhibition of epithelial NO production requires viable trophozoites but not cell-to-cell contact

We next investigated giardial requirements for the inhibition of epithelial NO production. Inhibition required viable trophozoites, because addition of heat-killed trophozoites did not affect NO production by cytokine-stimulated HT-29 cultures (110 µM NOx in uninfected controls, <2 µM NOx after addition of 3 x 106/well viable G. lamblia, and 111 µM NOx after addition of 3 x 106/well heat-killed G. lamblia). In contrast, cell-to-cell contact between G. lamblia trophozoites and epithelial cells was not required for inhibition of epithelial NO production. Thus, separation of HT-29 monolayers and trophozoites through a filter membrane (0.2 µm pore size) had no effect on the ability of G. lamblia to inhibit epithelial NO production by cytokine-stimulated HT-29 cells (no filter: 49 µM NOx in uninfected controls, <2 µM NOx after addition of 3 x 106/well trophozoites; with filter interposed: 51 µM NOx in controls, <2 µM NOx after addition of 3 x 106/well trophozoites). These findings indicate that the factor(s) responsible for the G. lamblia-induced inhibition of epithelial NO production is soluble and diffusable, suggesting that viable trophozoites released an inhibitory activity for epithelial NO production and/or consumed a crucial factor or substrate needed for this epithelial function.

G. lamblia infection has no effect on epithelial iNOS expression

NO production in epithelial and other cells is controlled at several levels, including the availability and transport of arginine and the levels of NOS, the critical rate-limiting enzyme for the conversion of arginine to NO. To define the role of the latter in the G. lamblia-induced inhibition of epithelial NO production, we focused on the expression of iNOS, because this isoform was previously shown to be the most abundant NOS isoform in intestinal epithelial cells (21, 22). Cytokine stimulation of HT-29 cells up-regulated iNOS mRNA and protein expression, as determined by RT-PCR and immunoblot analysis, respectively, but G. lamblia infection had no effect on this cellular response (Fig. 6Go). Thus, G. lamblia trophozoites did not release an inhibitory activity that interfered with the potential ability of intestinal epithelial cells to produce NO (i.e., as reflected in iNOS levels).



View larger version (57K):
[in this window]
[in a new window]
 
FIGURE 6. G. lamblia infection of HT-29 cultures has no effect on cytokine-induced iNOS expression. HT-29 cultures were left unstimulated (Cytokines, -), or were stimulated with a combination of IFN-{gamma}, IL-1{alpha}, and TNF-{alpha} (Cytokines, +). Cultures were left uninfected (G. lamblia, -) or were infected with 3 x 106 trophozoites/well (G. lamblia, +). After 18-h incubation, cultures were chilled, trophozoites were washed off, and cells were harvested. Total RNA was extracted and analyzed by RT-PCR for iNOS and ß-actin mRNA levels (A). As a control for the RT-PCR, RT-PCR amplification were performed without RNA (RNA, -). Levels of iNOS and actin protein were determined by immunoblot analysis (B). The Mr of iNOS and actin were 135 and 42 kDa, respectively.

 
Arginine consumption in G. lamblia-infected intestinal epithelial cell cultures

The finding that G. lamblia did not inhibit epithelial iNOS expression suggested that infection may reduce the availability or transport of a factor or substrate needed for NO production. Because G. lamblia is known to use arginine as an energy source (41, 42), and arginine is the crucial substrate needed for NOS to generate NO, we tested the hypothesis that G. lamblia reduces the availability of arginine in coculture with intestinal epithelial cells. As a first approach to test the hypothesis, we determined the levels of arginine in the supernatants from infected and control cultures by HPLC. As shown in Fig. 7GoA, G. lamblia infection of HT-29 cultures reduced arginine levels in the supernatants, with an inoculum/response curve similar to that for G. lamblia-induced inhibition of epithelial NO production (see Fig. 4GoA). At inocula of >=3 trophozoites/100 epithelial cells, arginine levels were reduced to <2% of those in uninfected control cultures. This effect became apparent <4 h after infection of the cultures, indicating rapid and highly efficient arginine uptake by G. lamblia under the coculture conditions. In contrast, G. lamblia infection either increased or did not affect the levels of several other amino acids, including glycine and asparagine (data not shown). These data indicate that the observed arginine decrease in G. lamblia-infected intestinal epithelial cell cultures is specific and not due to a generally increased consumption of amino acids by G. lamblia, a conclusion consistent with previous studies on amino acid consumption by G. lamblia trophozoites cultured in the absence of other cell types and in growth medium optimal for the parasite (41, 42).



View larger version (28K):
[in this window]
[in a new window]
 
FIGURE 7. Arginine consumption in G. lamblia-infected cultures of intestinal epithelial cells. A, Inoculum dependence of arginine levels in HT-29 cultures. Cultures were stimulated with a combination of IFN-{gamma}, IL-1{alpha}, and TNF-{alpha} and infected with the indicated inocula of G. lamblia trophozoites or left uninfected as controls. After 18 h, arginine levels were determined by HPLC. Each data point represents a single determination. Results from two separate experiments are shown. For comparison, the arginine level in the medium alone was 237 ± 35 µM (mean ± SEM; n = 4). B, Arginine levels in polarized Caco-2 cultures. Cultures of confluent polarized Caco-2 monolayers on collagen-coated microporous filter supports were stimulated on the basolateral side with a combination of IFN-{gamma}, IL-1{alpha}, and TNF-{alpha} (Cytokines, +) or were left unstimulated (Cytokines, -) and were infected on the apical side with about 107 trophozoites/well (G. lamblia, +) or were left uninfected (G. lamblia, -). After 18 h in culture, supernatants were removed separately from the apical and basolateral compartments, and arginine and glycine levels were determined by HPLC. For comparison, arginine levels in the medium used for the experiments are shown (Epithelial cells, -). Results are the mean ± SEM of three experiments. Asterisks indicate values significantly different (p < 0.05) from respective uninfected control values.

 
We next determined amino acid levels in the supernatants of polarized monolayers of Caco-2 cells. After 18 h, cultures of uninfected control monolayers had low but detectable levels of arginine in the apical compartment (10–15% of the level in culture medium) and ~2-fold increased arginine levels in the basolateral compartment compared with the culture medium alone (Fig. 7GoB), suggesting that the cells transported arginine from the apical to the basolateral compartment. Basolateral cytokine stimulation of the monolayers strongly increased epithelial NO production (Fig. 5GoA), but had no effect on apical arginine levels and decreased basolateral arginine levels only to a small extent (Fig. 7GoB). The latter decrease may reflect an increase in arginine uptake required for the cytokine-induced increase in NO production. When cytokine-stimulated cultures of polarized Caco-2 monolayers were infected with G. lamblia on the apical side, arginine levels decreased further in the apical compartment (to <1% of the level in culture medium) and were also reduced (by 60–70%) in the basolateral compartment compared with levels in cytokine-stimulated cultures that were not infected. In contrast to arginine, glycine was not significantly transported across control or cytokine-stimulated Caco-2 monolayers, nor were glycine levels affected by G. lamblia infection (Fig. 7GoB). Taken together, these findings indicate that G. lamblia consumed arginine in cultures of both nonpolarized and polarized intestinal epithelial cells. Moreover, in polarized epithelial monolayers, G. lamblia appeared to compete with the epithelial cells for arginine in the apical compartment, as suggested by the decreased amount of arginine that was transported by the epithelial cells from the apical to the basolateral compartment.

Arginine addition reverses G. lamblia-induced inhibition of epithelial NO production

To further test the hypothesis that G. lamblia inhibits epithelial NO production by reducing the availability of arginine, we next established the concentration/response relationship for the arginine dependence of epithelial NO production in uninfected cultures. Confluent HT-29 monolayers were cultured in arginine-free medium, supplemented with 10% dialyzed FCS, to which titrated amounts of arginine were added. Cells were stimulated for 18 h with a combination of cytokines (IL-1{alpha}, TNF-{alpha}, and IFN-{gamma}), and NO production was determined. Maximal NO production was observed when >=300 µM arginine was added to the cultures (97 ± 13 µM NOx at 300 µM arginine and 75 ± 9 µM NOx at 10 mM arginine; n = 4), while NO production was not detectable (<3 µM NOx) after addition of <=100 µM arginine. In contrast to NO production, IL-8 secretion was little affected by the lack of arginine in the cultures (376 ± 27 ng/ml IL-8 without arginine; 524 ± 64 ng/ml IL-8 with 10 mM arginine; n = 3). These data show that NO production by uninfected HT-29 cultures is critically dependent on the availability of exogenous arginine, and that the concentration/response relationship for this effect is consistent with the observed decrease in arginine levels after G. lamblia infection (Fig. 7GoA) and the concomitant decrease in NO production (Fig. 4GoA).

To further define the role of arginine in the G. lamblia-induced effects on epithelial NO production, we added increasing concentrations of exogenous arginine to G. lamblia-infected HT-29 cultures (which were set up in regular, arginine-containing medium). As shown in Fig. 8GoA, addition of increasing concentrations of arginine reversed the G. lamblia-induced inhibition of epithelial NO production. Thus, after addition of 1 mM or more arginine to G. lamblia-infected cultures, epithelial NO production was significantly higher than that in infected cultures not supplemented with arginine. Moreover, at the two highest concentrations of arginine added (3 and 10 mM), NO production in G. lamblia-infected cultures was not significantly different from that in uninfected control cultures. This effect was specific for NO production, because arginine addition to G. lamblia-infected HT-29 cultures did not significantly affect IL-8 secretion (Fig. 8GoB). Furthermore, the effect was specific for arginine, because addition of up to 10 mM serine, which is also consumed by G. lamblia (42), had no effect on the inhibition of epithelial NO production by G. lamblia (data not shown). Addition of up to 10 mM arginine or serine to uninfected control cultures had no effect on epithelial NO or IL-8 production (Fig. 8Go and data not shown). Taken together, these data show that arginine addition specifically and completely reversed the G. lamblia-induced inhibition of epithelial NO production.



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 8. Arginine addition reverses G. lamblia-induced inhibition of epithelial NO production. HT-29 cultures in regular medium were stimulated with a combination of IFN-{gamma}, IL-1{alpha}, and TNF-{alpha} and infected with 2–3 x 106 G. lamblia trophozoites/well (•) or left uninfected ({circ}). Arginine was added at the indicated concentrations 6 h after infection. Supernatants were removed 18 h after infection, and levels of NOx (i.e., NO2- and NO3-) were determined using the Griess reaction and nitrate reductase (A), and those of IL-8 were determined by ELISA (B). Data points represent the mean ± SEM of three independent experiments. Asterisks in A indicate values significantly different (p < 0.05) from those for respective controls not treated with arginine, as determined by Student’s t test. In B, none of the values from arginine-treated samples is significantly different (p > 0.05) from those in the respective controls not treated with arginine. Addition of arginine at the time of infection also reversed G. lamblia-induced inhibition of epithelial NO production, but the results were less consistent than those obtained when arginine was added 6 h after infection. This may be related to the higher arginine consumption by trophozoites early after infection.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
G. lamblia reside in close apposition to epithelial cells in the small intestine, suggesting epithelial cell-derived NO as a potential host defense against the pathogen. The present studies provide support for this concept, because NO profoundly inhibited growth and differentiation of G. lamblia. The potential importance of NO in giardial pathogenesis is further underlined by our finding that G. lamblia infection of human intestinal epithelial cell cultures inhibited epithelial NO production by limiting the availability of a crucial substrate, arginine, that is required for NO production by the host. This demonstrates that the parasite has strategies to counteract epithelial NO production as a potential host defense mechanism. Thus, based on the present studies, NO is at the center of several, mutually inhibitory interactions between G. lamblia and the host intestinal epithelium. These interactions differ from those previously reported for invasive and intracellular pathogens, which induce iNOS expression and NO production after invasion of host cells (18, 22, 26). Furthermore, the findings with the extracellular pathogen, G. lamblia, suggest a concept that may also apply to other extracellular pathogens, such as Entamoeba histolytica, that consume amino acids in the host microenvironment and where NO constitutes a potent host defense (43, 44).

NO inhibited both growth and encystation of G. lamblia trophozoites as well as excystation of cysts. Inhibitory effects on growth and excystation would be expected to reduce the number of trophozoites in the intestinal lumen, while inhibition of encystation might have the opposite effect, i.e., increased numbers of trophozoites in the lumen. The net outcome of these opposing effects is difficult to predict. However, growth inhibition may be important for the infected host, because local trophozoite growth is probably crucial for the ability of G. lamblia to establish and maintain infection of the proximal small bowel, whereas inhibition of encystation by NO could reduce the formation and passing of infectious cysts and, thereby, transmission to other potential hosts.

We found NO to be cytostatic, but not cytotoxic, for G. lamblia trophozoites, which is in contrast to a recent report that NO donors appeared to kill trophozoites in vitro (45). In that study the effects of NO donors were assessed in a minimal medium (buffered salt solution), which may have exaggerated the results, because such media do not support prolonged viability and growth of trophozoites even in the absence of NO donors. To avoid such complications, the present studies used complex medium to mimic in vivo conditions that allow long term survival and growth of G. lamblia trophozoites (35). Although it is clear that NO is cytostatic for trophozoites in complex medium, it is not known how NO exerts this effect. We have observed recently that trophozoite cultures exposed to NO donors appear to accumulate cells that are undergoing cell division (data not shown), which suggests that NO may affect the regulation of the giardial cell cycle, although little is currently known about mechanisms that govern cell cycle control in Giardia.

Our finding that G. lamblia and intestinal epithelial cells compete for arginine has several implications for understanding the interaction between pathogen and host. From the host perspective, reduced arginine availability could be considered a virulence mechanism of the pathogen, because it inhibited epithelial NO production, thereby subverting a potential host defense against G. lamblia. Both intestinal epithelial cells and G. lamblia trophozoites have highly efficient arginine transporter systems that have comparable substrate affinities, although the giardial arginine transport system has a 10- to 20-fold higher maximal transport capacity (46, 47, 48, 49), suggesting that Giardia may have an advantage over the host in taking up arginine. In addition, luminal arginine derived from food may encounter G. lamblia before it can be taken up by the epithelium, thus providing a further advantage for the pathogen over the host epithelium, although little is known about arginine levels in the intestinal lumen, extracellular space, or serum during giardial infection. However, a large fraction of arginine in food is in the form of peptides that need to be digested by peptidases before releasing free arginine. Many of the relevant peptidases are located on the apical membrane of intestinal epithelial cells, which may give the host epithelium an advantage over the trophozoites in taking up arginine. Furthermore, serum and, presumably, extracellular fluid contain moderate levels of free arginine (0.1–0.2 mM), and the intestinal epithelium is somewhat permeable for amino acids, which facilitates their diffusion from the serum or extracellular space into the intestinal lumen (50).

Giardial consumption of the substrate arginine required for epithelial NO production is clearly an important mechanism for G. lamblia-induced inhibition of epithelial NO production, as indicated by time course and inoculum/response curves for inhibition of NO production compared with those for arginine levels in the supernatants. However, the data do not exclude the possibility that trophozoites, in addition, may release an inhibitory activity for epithelial NO production. Comparison of concentration/response curves for the arginine dependence of NO production by HT-29 cells using arginine-free medium and regular medium previously conditioned by G. lamblia suggests that the parasite releases such an inhibitory activity, because higher levels of arginine are required for G. lamblia-conditioned medium compared with arginine-free medium to achieve the same levels of epithelial NO production (data not shown). One possibility for a G. lamblia-derived inhibitory activity for epithelial NO production would be the amino acid ornithine, which is released by G. lamblia in exchange for arginine (41, 42) and has been shown to competitively inhibit arginine uptake by epithelial cells (48). Based on this idea, G. lamblia could inhibit epithelial NO production by two separate, mutually reinforcing means: consumption of arginine and release of a competitor such as ornithine that inhibits arginine uptake by the intestinal epithelium.

G. lamblia inhibited NO production in polarized intestinal epithelial cell monolayers despite the fact that trophozoites resided exclusively on the apical side of the monolayers, and arginine depletion was mostly apparent on that side, whereas arginine levels on the basolateral side were only slightly lower than those in culture medium alone. These data suggest that polarized intestinal epithelial cells are largely dependent on apical arginine availability for NO production and do not substantially use arginine present on the basolateral side. Several lines of evidence support this interpretation. NO production in most cells depends completely on extracellular arginine despite the presence of sufficient arginine inside the cells (a phenomenon referred to as the arginine paradox) (51, 52). Efficient transport of extracellular arginine into cells is facilitated by several transporters, including those of the cationic amino acid transporter family of transporters, which are found in close association with some NOS isoforms and are thought to form a functional complex close to the membrane (51). In intestinal epithelial cells, iNOS is largely confined to the apical side of the cell underneath the cell membrane (23, 53), suggesting that functional cationic amino acid transporter/iNOS complexes are also limited to that side of the cell, although such complexes remain to be demonstrated in epithelial cells.

Intestinal epithelial cells are likely to be the most relevant NO-producing cells in the host for affecting giardial growth and differentiation due to the close association between the cells and G. lamblia. Cells immediately underlying the epithelium, e.g., subepithelial fibroblasts or macrophages, conceivably could also contribute a fraction of NO effective against Giardia via diffusion through the epithelial layer. In either case, expression of sufficiently high levels of one or several NOS isoforms by the relevant host cells is a necessary precondition for the release of effective amounts of NO to contribute to the host defense against G. lamblia. Intestinal epithelial cells in the distal small bowel in mice constitutively express iNOS mRNA (23), and isolated human duodenocytes produce NO constitutively (24). It is possible that epithelial iNOS expression may be up-regulated in vivo during the course of G. lamblia infection, although this is not known. Furthermore, inflammation of the proximal small bowel, which is likely to be accompanied by increased epithelial iNOS expression (25), is common in developing countries where coinfections with multiple enteric pathogens are prevalent (54). Under these conditions, increased epithelial iNOS expression caused by one pathogen may help to control infection with another pathogen, such as G. lamblia. This concept is illustrated, for example, by the finding that infection with Trichinella spiralis, which causes mucosal inflammation and increased iNOS mRNA expression in the proximal small bowel (55), interferes with subsequent Giardia infection (56).

Giardia resides strictly in the lumen of the intestinal tract. For effective control and removal of the parasite, the host has to rely on defense mechanisms that are active in the intestinal lumen. One such mechanism could be NO produced by the intestinal epithelium, as suggested by the present studies. Any role of NO in antigiardial defense is likely to be a complement to other luminally active defense mechanisms. For example, Abs are important for controlling Giardia infection because B cell-deficient mice cannot clear infections with Giardia, and secretory Abs of the IgA isotype are generally thought to be crucial for this function (9, 12, 13). However, the exact role of IgA in controlling G. lamblia infection is not clear, since patients with IgA deficiency have only a slight increase in the incidence of G. lamblia infection (14), and Xid mice cannot clear a primary G. muris infection despite high levels of antigiardial IgA Abs in mucosal secretions (10). This suggests that several levels of host defenses exist against Giardia, and that other host defense mechanisms may be able to compensate for the lack of secretory IgA. Furthermore, components of the natural immune system, such as defensins and lactoferrin, may contribute to host defense against Giardia by providing a base level protection against this pathogen (15, 16). Epithelial production of NO could also belong to this category of natural immune defenses. The balance between giardial arginine consumption and epithelial NO production could contribute to the variability in the duration and severity of infections by this ubiquitous parasite.


    Acknowledgments
 
We thank Steve Rossi and Alan Moore for conducting the HPLC analyses, and Leigh Knodler and Michael Dwinell for valuable comments on the manuscript.


    Footnotes
 
1 This work was supported by National Institutes of Health Grants DK35108 and AI24285 and by a Career Development Award and a research grant from the Crohn’s and Colitis Foundation of America (to L.E.). Back

2 Address correspondence and reprint requests to Dr. Lars Eckmann, Department of Medicine 0623D, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0623. E-mail address: Back

3 Current address: Station de Pathologie Aviaire et de Parasitologie, Institut National de la Recherche Agronomique Centre de Recherches de Tours, Nouzilly, France. Back

4 Abbreviations used in this paper: NOS, NO synthase; iNOS, inducible NOS; GSNO, S-nitrosoglutathione; GSSG, oxidized glutathione; spermine NONOate, 1-N-[3-aminopropyl]-N-[4-(3-aminopropylammonio)butyl]-amino-diazen-1-ium-1,2-diolate; CWP2, cyst wall protein 2; ESV, encystation-specific secretory vesicle. Back

Received for publication August 9, 1999. Accepted for publication November 22, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Flanagan, P. A.. 1992. Giardia–diagnosis, clinical course and epidemiology: a review. Epidemiol. Infect. 109:1.[Medline]
  2. Nash, T. E., D. A. Herrington, G. A. Losonsky, M. M. Levine. 1987. Experimental human infections with Giardia lamblia. J. Infect. Dis. 156:974.[Medline]
  3. Smith, P. D., F. D. Gillin, W. M. Spira, T. E. Nash. 1982. Chronic giardiasis: studies on drug sensitivity, toxin production, and host immune response. Gastroenterology 83:797.[Medline]
  4. Adam, R. D.. 1991. The biology of Giardia spp. Microbiol. Rev. 55:706.[Abstract/Free Full Text]
  5. Erlandsen, S. L., and D. E. Feely. 1984. Trophozoite motility and mechanisms of attachment. In Giardia and Giardiasis: Biology, Pathogenesis, and Epidemiology. S. L. Erlandsen and E. A. Meyers, eds. Plenum Press, New York, p. 32.
  6. Gillin, F. D., D. S. Reiner, J. M. McCaffery. 1996. Cell biology of the primitive eukaryote Giardia lamblia. Annu. Rev. Microbiol. 50:679.[Medline]
  7. Oberhuber, G., N. Kastner, M. Stolte. 1997. Giardiasis: a histologic analysis of 567 cases. Scand. J. Gastroenterol. 32:48.[Medline]
  8. Heyworth, M. F., J. R. Carlson, T. H. Ermak. 1987. Clearance of Giardia muris infection requires helper/inducer T lymphocytes. J. Exp. Med. 165:1743.[Abstract/Free Full Text]
  9. Snider, D. P., J. Gordon, M. R. McDermott, B. J. Underdown. 1985. Chronic Giardia muris infection in anti-IgM-treated mice. I. Analysis of immunoglobulin and parasite-specific antibody in normal and immunoglobulin-deficient animals. J. Immunol. 134:4153.[Abstract]
  10. Snider, D. P., D. Skea, B. J. Underdown. 1988. Chronic giardiasis in B-cell-deficient mice expressing the xid gene. Infect. Immun. 56:2838.[Abstract/Free Full Text]
  11. Heyworth, M. F., J. E. Kung, E. C. Eriksson. 1986. Clearance of Giardia muris infection in mice deficient in natural killer cells. Infect. Immun. 54:903.[Abstract/Free Full Text]
  12. Stager, S., N. Müller. 1997. Giardia lamblia infections in B-cell-deficient transgenic mice. Infect. Immun. 65:3944.[Abstract]
  13. Heyworth, M. F.. 1989. Intestinal IgA responses to Giardia muris in mice depleted of helper T lymphocytes and in immunocompetent mice. J. Parasitol. 75:246.[Medline]
  14. Strober, W., M. C. Sneller. 1991. IgA deficiency. Ann. Allergy 66:363.[Medline]
  15. Aley, S. B., M. Zimmerman, M. Hetsko, M. E. Selsted, F. D. Gillin. 1994. Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect. Immun. 62:5397.[Abstract/Free Full Text]
  16. Turchany, J. M., S. B. Aley, F. D. Gillin. 1995. Giardicidal activity of lactoferrin and N-terminal peptides. Infect. Immun. 63:4550.[Abstract]
  17. Clark, I. A., K. A. Rockett. 1996. Nitric oxide and parasitic disease. Adv. Parasitol. 37:1.[Medline]
  18. James, S. L.. 1995. Role of nitric oxide in parasitic infections. Microbiol. Rev. 59:533.[Abstract/Free Full Text]
  19. Fang, F. C.. 1997. Perspectives series: host/pathogen interactions: mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. 99:2818.[Medline]
  20. Alican, I., P. Kubes. 1996. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am. J. Physiol. 270:G225.[Abstract/Free Full Text]
  21. Salzman, A., A. G. Denenberg, I. Ueta, M. O’Connor, S. C. Linn, C. Szabo. 1996. Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am. J. Physiol. 270:G565.[Abstract/Free Full Text]
  22. Witthöft, T., L. Eckmann, J. M. Kim, M. F. Kagnoff. 1998. Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. Am. J. Physiol. 275:G564.[Abstract/Free Full Text]
  23. Hoffman, R. A., G. Zhang, N. C. Nussler, S. L. Gleixner, H. R. Ford, R. L. Simmons, S. C. Watkins. 1997. Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa. Am. J. Physiol. 272:G383.[Abstract/Free Full Text]
  24. Murray, I. A., K. Coupland, I. D. Daniels, W. P. Goddard, R. G. Long. 1998. iNOS is expressed by unstimulated human duodenal enterocytes in vitro with increased expression in disease. Gastroenterology 114:A1046. (Abstr.).
  25. Singer, I. I., D. W. Kawka, S. Scott, J. R. Weidner, R. A. Mumford, T. E. Riehl, W. F. Stenson. 1996. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111:871.[Medline]
  26. Salzman, A. L., T. Eaves-Pyles, S. C. Linn, A. G. Denenberg, C. Szabo. 1998. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 114:93.[Medline]
  27. Meng, T. C., M. L. Hetsko, F. D. Gillin. 1996. Inhibition of Giardia lamblia excystation by antibodies against cyst walls and by wheat germ agglutinin. Infect. Immun. 64:2151.[Abstract]
  28. Boucher, S. E., F. D. Gillin. 1990. Excystation of in vitro-derived Giardia lamblia cysts. Infect. Immun. 58:3516.[Abstract/Free Full Text]